Labcorp Acquires MLM Medical Labs To Expand Global Clinical Trial Laboratory Network

Labcorp has acquired MLM Medical Labs, a global central and specialty laboratory provider with operations across the United States, Germany, and South Africa. Financial terms of the transaction were not disclosed.

The acquisition expands Labcorp’s international central laboratory footprint and strengthens its biomarker and specialty testing capabilities for clinical trials.

Following the transaction, Labcorp said it becomes the only central laboratory provider with a wholly owned laboratory network spanning four continents: North America, Europe, Asia, and Africa.

The combination brings together Labcorp’s scientific capabilities, operational infrastructure, and global scale with MLM’s existing laboratory network and specialty testing operations.

Labcorp expects the expanded network to support complex multinational clinical trials with more consistent scientific, regulatory, and operational oversight. The acquisition also increases Labcorp’s presence in Africa, where MLM operates what the companies describe as the continent’s first fully CAP-accredited central laboratory.

Labcorp said the additional biomarker, specialty testing, and regulatory capabilities are increasingly important as drug development programs become more scientifically complex and clinical trials involve broader international patient populations.

Evercore served as exclusive financial advisor to Labcorp. Pierson Ferdinand and Hogan Lovells served as legal counsel.

KEY QUOTES:

“Clinical trial sponsors today need scientific expertise, global reach and operational flexibility to advance increasingly complex development programs. MLM complements Labcorp’s existing strengths and enhances our ability to support sponsors of all sizes, from emerging biotechs to leading pharmaceutical companies. Together, we are well positioned to provide the capabilities, regional expertise and high-touch support sponsors need to advance innovative therapies worldwide.”

Brian Caveney, M.D., EVP and President of Biopharma Laboratory Services and Chief Medical and Scientific Officer at Labcorp